Affiliation:
1. School of Pharmacy Shenzhen University Medical School Shenzhen University Institute for Inheritance-Based Innovation of Chinese Medicine Marshall Laboratory of Biomedical Engineering Shenzhen 518060 People's Republic of China
2. Guangdong Pharmaceutical University Guangzhou 510006 People's Republic of China
Abstract
AbstractIn our previous work, an indolone derivative ZL170 was isolated and identified from Periplaneta americana (P. americana). Based on its characteristic structure, we used it as a lead compound to carry out structural optimization and subsequent antitumor activity evaluation. In the present study, a series of novel indolone derivatives bearing thiazole scaffold were designed and synthesized, and their antitumor activities against triple‐negative breast cancer (TNBC) were determined. The preliminary screening results showed that LJ3, LJ8, LJ23, and LJ27 display inhibition rates of over 60 % against MDA‐MB‐231cells at the concentration of 50 μM. Notably, LJ23 demonstrated an IC50 value of 32.19 μM against MDA‐MB‐231, prompting further evaluation of its inhibitory effect on TNBC cell motility. Results revealed that LJ23 effectively hindered TNBC cell migration through downregulation of the EMT process. Additionally, molecular docking was employed to predict the interaction mode between LJ23 and phosphoinositide 3‐kinase (PI3K).